Search research articles
Contact Us
Filters
Showing results (21-30 of 38) with videos related to
Page
of 4
Sort By:
Anti-Cancer Drugs
|
February 1, 1997
Chemosensitization and drug accumulation effects of VX-710, verapamil, cyclosporin A, MS-209 and GF120918 in multidrug resistant HL60/ADR cells expressing the multidrug resistance-associated protein MRP
U A Germann, P J Ford, D Shlyakhter, et al.
The Journal of Biological Chemistry
|
March 5, 1992
Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase
B Sarkadi, E M Price, R C Boucher, et al.
Journal of Bioenergetics and Biomembranes
|
February 1, 1995
Effects of phosphorylation of P-glycoprotein on multidrug resistance
U A Germann, T C Chambers, S V Ambudkar, et al.
Annals of the New York Academy of Sciences
|
May 31, 1994
Gene transfer of drug resistance genes. Implications for cancer therapy
M M Gottesman, U A Germann, I Aksentijevich, et al.
Biochemistry
|
October 21, 1999
Both ATP sites of human P-glycoprotein are essential but not symmetric
C A Hrycyna, M Ramachandra, U A Germann, et al.
Genes, Chromosomes & Cancer
|
August 1, 1994
Putative "MDR enhancer" is located on human chromosome 20 and not linked to the MDR1 gene on chromosome 7
U A Germann, P V Schoenlein, D B Zimonjic, et al.
The Journal of Biological Chemistry
|
August 25, 1985
(Cu,Zn)-metallothioneins from fetal bovine liver. Chemical and spectroscopic properties
K Münger, U A Germann, M Beltramini, et al.
Biochemistry
|
October 31, 1995
Bacterial expression of the linker region of human MDR1 P-glycoprotein and mutational analysis of phosphorylation sites
T C Chambers, U A Germann, M M Gottesman, et al.
Biochemistry
|
September 30, 1998
Structural flexibility of the linker region of human P-glycoprotein permits ATP hydrolysis and drug transport
C A Hrycyna, L E Airan, U A Germann, et al.
Current Medicinal Chemistry
|
September 25, 1999
Inhibitors of p38 MAP kinase: therapeutic intervention in cytokine-mediated diseases
F G Salituro, U A Germann, K P Wilson, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 38) with videos related to
Sort By:
Page
of 4
Anti-Cancer Drugs
|
February 1, 1997
Chemosensitization and drug accumulation effects of VX-710, verapamil, cyclosporin A, MS-209 and GF120918 in multidrug resistant HL60/ADR cells expressing the multidrug resistance-associated protein MRP
U A Germann, P J Ford, D Shlyakhter, et al.
The Journal of Biological Chemistry
|
March 5, 1992
Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase
B Sarkadi, E M Price, R C Boucher, et al.
Journal of Bioenergetics and Biomembranes
|
February 1, 1995
Effects of phosphorylation of P-glycoprotein on multidrug resistance
U A Germann, T C Chambers, S V Ambudkar, et al.
Annals of the New York Academy of Sciences
|
May 31, 1994
Gene transfer of drug resistance genes. Implications for cancer therapy
M M Gottesman, U A Germann, I Aksentijevich, et al.
Biochemistry
|
October 21, 1999
Both ATP sites of human P-glycoprotein are essential but not symmetric
C A Hrycyna, M Ramachandra, U A Germann, et al.
Genes, Chromosomes & Cancer
|
August 1, 1994
Putative "MDR enhancer" is located on human chromosome 20 and not linked to the MDR1 gene on chromosome 7
U A Germann, P V Schoenlein, D B Zimonjic, et al.
The Journal of Biological Chemistry
|
August 25, 1985
(Cu,Zn)-metallothioneins from fetal bovine liver. Chemical and spectroscopic properties
K Münger, U A Germann, M Beltramini, et al.
Biochemistry
|
October 31, 1995
Bacterial expression of the linker region of human MDR1 P-glycoprotein and mutational analysis of phosphorylation sites
T C Chambers, U A Germann, M M Gottesman, et al.
Biochemistry
|
September 30, 1998
Structural flexibility of the linker region of human P-glycoprotein permits ATP hydrolysis and drug transport
C A Hrycyna, L E Airan, U A Germann, et al.
Current Medicinal Chemistry
|
September 25, 1999
Inhibitors of p38 MAP kinase: therapeutic intervention in cytokine-mediated diseases
F G Salituro, U A Germann, K P Wilson, et al.
Page
of 4